UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

May 2019

 

Commission file number: 001-36288

 

Akari Therapeutics, Plc

(Translation of registrant's name into English)

 

75/76 Wimpole Street

London W1G 9RT

United Kingdom

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x        Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

  

 

 

 

 

 

CONTENTS

 

On May 28, 2019, Akari Therapeutic, Plc (the “Company”) announced that it will hold its Annual General Meeting of Shareholders on June 27, 2019.  In connection with the meeting, the Company furnished the following documents:

 

  1. Notice and Proxy Statement to Shareholders dated May 28, 2019

  

  2. Form of Proxy Card

 

The information contained in this report (including the exhibits hereto) is hereby incorporated by reference into all effective registration statements filed by the Company under the Securities Act of 1933.

 

Exhibit No.

 

99.1 Notice of Annual General Meeting of Shareholders and Proxy Statement

  

99.2 Form of Proxy Card

  

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Akari Therapeutics, Plc  
  (Registrant)  
       
  By: /s/ Clive Richardson  
  Name:   Clive Richardson  
    Interim Chief Executive Officer and Chief Operating Officer

        

Date: May 29, 2019

 

 

 

 

 

 

 

 

 

 

 

 

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Akari Therapeutics Charts.
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Akari Therapeutics Charts.